Three Filing-Backed Surges, Zero Higher Afterward
KOSPI and the S&P 500 each fell about 8% on the week. We re-checked every surging stock we covered, by verdict. The 3 filing-backed names were all flat or lower afterward; the 17 report-only names averaged -4.7%.

Seoul — Korean and U.S. stocks fell together this week. According to Paper Trail's own market notes, KOSPI lost 7.95% and the S&P 500 lost 8.56% on the week. Among the surging stocks we covered, the 3 rated "filing" were not higher afterward. They averaged -11.7%. The 17 rated "report only" averaged -4.7%. With only 3 names on the filing side, the sample is too small to draw conclusions.
This week's market
Paper Trail's notes say every index and every sector fell. Weekly moves: S&P 500 -8.56%, Nasdaq 100 -10.51%, KOSPI -7.95%, KOSDAQ -7.72%. The VIX rose 85.96% from the prior week, and the Fear & Greed index dropped to 9.7 (extreme fear).
Friday (Nov 20) was the worst day. KOSPI fell 5.21% to 4,869.96 and KOSDAQ fell 5.71% to 645.68. In the U.S., the S&P 500 fell 3.7% and the Nasdaq Composite fell 5.28%.
The notes cite worries over AI investment returns as the main cause (partly estimated). Big Tech is spending heavily on AI, and doubts about a clear path to profit spread into semiconductors and tech. The SMH chip ETF fell 17.81% on the week. Health care (XLV, -6.15%) fell the least. Gold and WTI also fell, which the notes say may point to broad selling across risk assets (estimate).
The stocks we covered, and what came after
This week we wrote up 6 stocks. Gap, Global Payments, Bbia and HLB Life Science were covered on Nov 20, the last trading day of the week. They have had no trading day since, so we left them out of the comparison.
| Stock | Verdict then | Move that day | Move since | One line |
|---|---|---|---|---|
| Gap | Earnings | +11.44% | No trading day | Q3 results 8-K; full-year sales guidance cut, per news |
| Global Payments | Report | +9.95% | No trading day | Report that top holder GTCR is weighing a takeover |
| Bbia | Sector report | +29.95% | No trading day | Cosmetics stocks rose on hopes of better Korea-China ties |
| HLB Life Science | Filing | +15.97% | No trading day | Merger decision filing |
| Insmed | Report | +20.58% | -2.2% | Report of a Sanofi bid; no filing |
| TELUS | Report | +13.35% | +2.7% | Barclays upgrade reported |
The scorecard for the whole week, by verdict: 17 report-only stocks averaged -4.7%, and 4 of them rose. The 3 filing stocks averaged -11.7%, and none rose. The 7 "other" stocks averaged -9.8%, and none rose. The one "no reason" stock, Yeseon Tech, was down 14.0%. These averages count the four stocks with no trading day since as 0%: Gap, Global Payments, Bbia and HLB Life Science.
Filing. CG Oncology fell 6.3% and SELLAS Life Sciences fell 28.7%. HLB Life Science has had no trading day since. SELLAS had jumped 156.36% on its day. A filing did not hold the price up afterward. But this is 3 names, one of them untested, so the record is effectively 2.
Report only. Of 17 stocks, only TELUS (+15.7%), Netskope (+4.0%), Big Wave Robotics (+3.0%) and Jisen (+2.3%) rose. Namuga (-20.3%), LK Samyang (-20.2%) and Gyeyang Electric (-17.2%) gave back about a fifth. Insmed and TELUS are only a day past their write-ups, so their -2.2% and +2.7% are small moves.
Other and no reason. Optonics rose 46.25% on its day and fell 49.2% afterward, the biggest reversal of the week. Yeseon Tech rose with no reason we could find and then fell 14.0%. The "no reason" group is one stock.
It was also a week when the whole market fell. Negative returns after our write-ups cannot be pinned on the verdicts alone.
Next week's calendar
Events listed in the notes:
- Nov 25: GDP and PCE inflation. The notes call PCE a key input before the Dec 9 FOMC.
- Dec 1: JOLTS job openings
- Dec 4: Nonfarm payrolls
- Dec 9 (U.S.) / early Dec 10 (Korea): FOMC rate decision
- Dec 10: CPI